TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 101317

Group type: EXPERIMENTAL
Intervention: Aqueous pollen extract (SDV), 18 doses
Number of subjects: 153

Group type: COMPARATOR
Intervention: Glutaraldehyde-treated pollen-tyrosine adsorbate (Pollinex), 3 doses
Number of subjects: 153
Study: 31682941

Group type: EXPERIMENTAL
Intervention: Digital DPP (small group support, personalized health coaching, digital tracking tools, weekly behavior change curriculum)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Small group in-person class
Number of subjects: 241
Study: 30588860

Group type: EXPERIMENTAL
Intervention: α‐HICA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HMB‐FA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: HMB‐Ca
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 40
Study: 27570184

Group type: EXPERIMENTAL
Intervention: Food Attention Control Training Program (Food-ACTP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No-intervention (control)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham-intervention
Number of subjects: 49
Study: 24778436

Group type: EXPERIMENTAL
Intervention: Baby Triple P (8 sessions) + Treatment as Usual (TAU)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 27
Study: 23768119

Group type: EXPERIMENTAL
Intervention: Tailored Interactive Health Communication Application (IHCA)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Standard website (control)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Tailored IHCA
Number of subjects: 414
Study: 21888642

Group type: EXPERIMENTAL
Intervention: Smart Salt (50% sodium chloride, 25% potassium chloride, 25% magnesium ammonium potassium chloride)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Regular salt (NaCl)
Number of subjects: 45
Study: 20027086

Group type: EXPERIMENTAL
Intervention: All 5-mm ports approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 40
Study: 17908750

Group type: EXPERIMENTAL
Intervention: Breast milk ingestion during NICU hospitalization
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Increase in breast milk ingestion (10 mL/kg per day)
Number of subjects: 773

Group type: COMPARATOR
Intervention: No breast milk ingestion
Number of subjects: 773
Study: 14661081

Group type: EXPERIMENTAL
Intervention: Doxadent (DD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Tetric Ceram/Syntac Single-Component (TC/SS)
Number of subjects: 8
Study: 16225606

Group type: EXPERIMENTAL
Intervention: Excimer laser treatment (twice weekly)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment (every 4 weeks, pretreated with salicylic acid)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Salicylic acid alone (control)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Untreated control plaques
Number of subjects: 22
Study: 11858005

Group type: EXPERIMENTAL
Intervention: Evaluative sciences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assessing efficacy, (cost‐)effectiveness, and cost‐utility of clinical technologies
Number of subjects: 0
Study: 9059669

Group type: EXPERIMENTAL
Intervention: Topical steroid treatment for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 8337620

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 461
Study: 3567121

Group type: EXPERIMENTAL
Intervention: Oxytocin titration to achieve a preset frequency of 6-7 uterine contractions every 15 min
Number of subjects: 114

Group type: COMPARATOR
Intervention: Oxytocin titration to achieve uterine activity equivalent to the 75th centile for spontaneous labour
Number of subjects: 114
Study: 2523581

Group type: EXPERIMENTAL
Intervention: 4-hour back school psychoeducational session (LBS)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: 1-year 'compliance package' program (CP)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 222
Study: 31237250

Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification Training (ABMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham ABMT (Control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ABMT
Number of subjects: 33
Study: 27112919

Group type: EXPERIMENTAL
Intervention: Narrative writing intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no narrative writing)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 70
Study: 24966113

Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise program (FlexToBa™)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Healthy aging DVD control group
Number of subjects: 307
Study: 23585499

Group type: EXPERIMENTAL
Intervention: Participatory intervention to improve psychosocial work environment for 6 months
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 434
Study: 21406450

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Autologous blood injection (ABI)
Number of subjects: 150
Study: 19136752

Group type: EXPERIMENTAL
Intervention: Caudal block with bupivacaine and sufentanil combination
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 30
Study: 18027161

Group type: EXPERIMENTAL
Intervention: Baseline FEV(1)/FVC ratio<0.7
Number of subjects: 3041

Group type: EXPERIMENTAL
Intervention: Baseline airflow obstruction and FEV(1)<60%
Number of subjects: 3041
Study: 15466899

Group type: EXPERIMENTAL
Intervention: Psychological intervention (motivational interviewing, coping skills training, social support)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 91
Study: 11605555

Group type: EXPERIMENTAL
Intervention: Confidence judgments required after each comparative judgment (sessions 5-8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No confidence judgments required (sessions 1-4 and 9-12)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-alternative comparative judgments of Canadian city populations
Number of subjects: 0
Study: 9851505

Group type: EXPERIMENTAL
Intervention: EESC‐DCR
Number of subjects: 60

Group type: COMPARATOR
Intervention: EXT‐DCR
Number of subjects: 60
Study: 8133476

Group type: EXPERIMENTAL
Intervention: Trimethoprim sulfate 0.1%/polymyxin B sulfate
Number of subjects: 99

Group type: COMPARATOR
Intervention: Tobramycin 0.3%
Number of subjects: 99
Study: 2553235

Group type: EXPERIMENTAL
Intervention: Weekly doxorubicin (ADR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Triweekly doxorubicin (ADR)
Number of subjects: 102
Study: 960908

Group type: EXPERIMENTAL
Intervention: +)-cyanidanol-3 (2 g daily, administered orally)
Number of subjects: 28

Group type: COMPARATOR
Intervention: +)-cyanidanol-3 (1 g daily)
Number of subjects: 28
Study: 31744425

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT) with Trevo stent retriever
Number of subjects: 107

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 107

Group type: COMPARATOR
Intervention: >=3 passes with stent retriever
Number of subjects: 107

Group type: COMPARATOR
Intervention: Baseline National Institutes of Health Stroke Scale score >17
Number of subjects: 107
Study: 31315799

Group type: EXPERIMENTAL
Intervention: Intracutaneous suturing
Number of subjects: 280

Group type: COMPARATOR
Intervention: Stapling
Number of subjects: 280
Study: 25184738

Group type: EXPERIMENTAL
Intervention: Simulated refundable tax credit
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no tax credit)
Number of subjects: 130
Study: 23945134

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 4 or 8 mg/kg every four weeks
Number of subjects: 585

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Baseline C1M levels
Number of subjects: 585
Study: 21861607

Group type: EXPERIMENTAL
Intervention: Safer Sex Skills Building (SSB) intervention
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Female condom demonstration session
Number of subjects: 515
Study: 19965519

Group type: EXPERIMENTAL
Intervention: Interferon-beta 1a (intramuscular)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Previous interferon-beta preparation (subcutaneous)
Number of subjects: 24
Study: 17978323

Group type: EXPERIMENTAL
Intervention: In-patient treatment
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Specialist out-patient treatment
Number of subjects: 167

Group type: COMPARATOR
Intervention: General CAMHS treatment
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Overall recovery rates
Number of subjects: 167
Study: 14967215

Group type: EXPERIMENTAL
Intervention: Grapheme-phoneme convergence
Number of subjects: 14

Group type: COMPARATOR
Intervention: Visual orthographic factors
Number of subjects: 14
Study: 11329564

Group type: EXPERIMENTAL
Intervention: Esophagogastric dissociation (EGD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fundoplication and gastrostomy
Number of subjects: 29
Study: 9494148

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg orally per day
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg orally per day
Number of subjects: 541

Group type: COMPARATOR
Intervention: Ranitidine 150 mg orally twice a day
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg per day (maintenance)
Number of subjects: 541

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice a day (maintenance)
Number of subjects: 541
Study: 8307222

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid/dipyridamole (50 mg/400 mg daily)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 3144173

Group type: EXPERIMENTAL
Intervention: Acetate (160 mmol acetate/d replacing 160 mmol chloride/d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No added acetate
Number of subjects: 12
Study: 30884964

Group type: EXPERIMENTAL
Intervention: 3‐OHB infusion
Number of subjects: 16
Study: 27798513

Group type: EXPERIMENTAL
Intervention: Everolimus (EVL) with target trough level (Ctrough, 3‐8 ng/mL), prednisone, and tacrolimus (TCL) (target Ctrough, 2‐5 ng/mL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Everolimus (EVL)
Number of subjects: 16
Study: 26501937

Group type: EXPERIMENTAL
Intervention: PDS group (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-PDS group (n=15)
Number of subjects: 30
Study: 25475464

Group type: EXPERIMENTAL
Intervention: Optimal medical management (OMT)
Number of subjects: 1192

Group type: COMPARATOR
Intervention: Initial revascularization plus OMT
Number of subjects: 1192

Group type: EXPERIMENTAL
Intervention: Severity of angina during the first 6 months
Number of subjects: 1192
Study: 22582933

Group type: EXPERIMENTAL
Intervention: Psychotropic medications (specific drugs not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19545249

Group type: EXPERIMENTAL
Intervention: MAP0004 0.5 mg
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: MAP0004 1.0 mg
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: MAP0004
Number of subjects: 86
Study: 17314579

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3%, 3 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 40
Study: 15377581

Group type: EXPERIMENTAL
Intervention: Fast-tracking (FT) group
Number of subjects: 207

Group type: COMPARATOR
Intervention: Routine group (Control)
Number of subjects: 207
Study: 11474143

Group type: EXPERIMENTAL
Intervention: Sensorial saturation (SS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 10% oral glucose plus sucking
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no analgesia)
Number of subjects: 17
Study: 9684795

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa) injection, doses ranging from 5 to 320 microg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa) injection, doses < or = 20 microg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa) injection, doses > 20 microg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa) injection
Number of subjects: 28
Study: 7766962

Group type: EXPERIMENTAL
Intervention: Food A (3.12 g protein equivalent per 100 kcal)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Food B (2.74 g protein equivalent per 100 kcal)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Food A
Number of subjects: 25

Group type: COMPARATOR
Intervention: Food B
Number of subjects: 25
Study: 3144009

Group type: EXPERIMENTAL
Intervention: Protein supply (1 g protein/kg.d) and 1-carnitine (2 g/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (same regimen as treated group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Protein supply and 1-carnitine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31610383

Group type: EXPERIMENTAL
Intervention: BISQ-R scoring algorithm applied to data sample 1 (33,835 submissions)
Number of subjects: 33835

Group type: EXPERIMENTAL
Intervention: BISQ-R scoring algorithm applied to data sample 2 (16,531 submissions)
Number of subjects: 33835

Group type: EXPERIMENTAL
Intervention: BISQ-R scoring algorithm applied to data sample 3 (web-based ecology study)
Number of subjects: 33835

Group type: EXPERIMENTAL
Intervention: BISQ-R scoring algorithm applied to data sample 4 (longitudinal study)
Number of subjects: 33835

Group type: EXPERIMENTAL
Intervention: BISQ-R scoring algorithm applied to data sample 5 (randomized control trial behavioral intervention study)
Number of subjects: 33835
Study: 28343938

Group type: EXPERIMENTAL
Intervention: Testosterone (T) administered 2-3 hours prior to testing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo administered 2-3 hours prior to testing
Number of subjects: 16
Study: 23952097

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1 g IV every 8 hours for up to 24 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (physiologic saline every 8 hours for up to 24 hours)
Number of subjects: 100
Study: 23731246

Group type: EXPERIMENTAL
Intervention: aPCC prophylaxis
Number of subjects: 19
Study: 20147742

Group type: EXPERIMENTAL
Intervention: EpCAM+CK+CD45- objects
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Prediction model including large tumor cell fragments (L-TCF), age, hemoglobin and lactate dehydrogenase
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Models with S-TMP or CTC instead of L-TCF
Number of subjects: 179
Study: 18538990

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 1690

Group type: COMPARATOR
Intervention: Mail interview
Number of subjects: 1690
Study: 15695937

Group type: EXPERIMENTAL
Intervention: Home-based walking program
Number of subjects: 90
Study: 12552047

Group type: EXPERIMENTAL
Intervention: Stroke Impact Scale-16 (SIS-16)
Number of subjects: 621

Group type: COMPARATOR
Intervention: Barthel Index (BI)
Number of subjects: 621
Study: 11763907

Group type: EXPERIMENTAL
Intervention: 1.0% ZCT essential oil dentifrice
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: 2.0% ZCT essential oil dentifrice
Number of subjects: 196

Group type: COMPARATOR
Intervention: Crest Regular dentifrice
Number of subjects: 196
Study: 8857096

Group type: EXPERIMENTAL
Intervention: 4F catheter/sheath system
Number of subjects: 244
Study: 8157902

Group type: EXPERIMENTAL
Intervention: Lidocaine (bolus i.v. of 1 mg/kg, followed by an infusion of 4 mg/min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (infusion of saline at a rate of 1 mL/min)
Number of subjects: 60
Study: 3530156

Group type: EXPERIMENTAL
Intervention: Chloroquine (10 mg base kg-1)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Chlorproguanil (1.5 mg kg-1)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Pyrimethamine
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo (vitamin tablets)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Untreated group from the fifth village
Number of subjects: 282
Study: 28884824

Group type: EXPERIMENTAL
Intervention: Anacetrapib (5 to 500 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 24446988

Group type: EXPERIMENTAL
Intervention: Differential training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Traditional training
Number of subjects: 14
Study: 22468572

Group type: EXPERIMENTAL
Intervention: Group Psychodynamic Interpersonal Psychotherapy (GPIP)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Group Cognitive Behavioral Therapy (GCBT)
Number of subjects: 95
Study: 20004542

Group type: EXPERIMENTAL
Intervention: Irbesartan (300mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (12.5mg)
Number of subjects: 36
Study: 17122980

Group type: EXPERIMENTAL
Intervention: RF-assisted laparoscopic liver resection (LLR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non RF-assisted laparoscopic liver resection (LLR)
Number of subjects: 45
Study: 15691261

Group type: EXPERIMENTAL
Intervention: VapoMeter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tewameter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 0
Study: 12100701

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate foam
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo foam
Number of subjects: 81
Study: 10500310

Group type: EXPERIMENTAL
Intervention: MTHFR C677T mutation
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Age and BMI
Number of subjects: 95

Group type: COMPARATOR
Intervention: Serum total homocysteine and MTHFR polymorphism
Number of subjects: 95
Study: 8906937

Group type: EXPERIMENTAL
Intervention: Topical flurbiprofen
Number of subjects: 90

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 90
Study: 2651233

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg/day
Number of subjects: 2276

Group type: EXPERIMENTAL
Intervention: Nifedipine titrated to 60 mg/day
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2276
Study: 793562

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, 20 mg orally daily at 8 PM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate, up to 40 mg orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate
Number of subjects: 0
Study: 31486726

Group type: EXPERIMENTAL
Intervention: Nurse-led telephonic case management
Number of subjects: 9

Group type: COMPARATOR
Intervention: Specialty outpatient palliative care
Number of subjects: 9
Study: 27342301

Group type: EXPERIMENTAL
Intervention: Computerized cognitive intervention (23 ALL/11 BT)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control group (24 ALL/10 BT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Computerized cognitive intervention
Number of subjects: 68
Study: 26007292

Group type: EXPERIMENTAL
Intervention: Single-tooth tenaculum
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vulsellum
Number of subjects: 80
Study: 23528880

Group type: EXPERIMENTAL
Intervention: Comprehensive group program (psychoeducation, cognitive rehabilitation, cognitive behavioral therapy)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Comprehensive group program
Number of subjects: 84
Study: 22204420

Group type: EXPERIMENTAL
Intervention: 12 weeks individualised nutritional counselling by a registered dietician complemented with follow‐up by general practitioners
Number of subjects: 160

Group type: COMPARATOR
Intervention: 12 weeks follow‐up by general practitioners alone
Number of subjects: 160
Study: 19735564

Group type: EXPERIMENTAL
Intervention: Structured information programme for nursing staff, information materials for legal guardians and residents' relatives, and a one-day training workshop for nominated nurses.
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Standard information (control group).
Number of subjects: 3000
Study: 16526585

Group type: EXPERIMENTAL
Intervention: Individually prescribed activities
Number of subjects: 30
Study: 15454375

Group type: EXPERIMENTAL
Intervention: CardioVention system (hybrid pump)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional on-pump surgery
Number of subjects: 10
Study: 11092795

Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire (HAQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SF-36 (generic measure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain score
Number of subjects: 0
Study: 9396958

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (20 Hz at 80% motor threshold)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 12
Study: 8333598

Group type: EXPERIMENTAL
Intervention: Acute dose of alcohol
Number of subjects: 0
Study: 3447334

Group type: EXPERIMENTAL
Intervention: Subconjunctival 5-fluorouracil (5-FU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No antimetabolite treatment
Number of subjects: 0
Study: 29414735

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with topical application of 50 μl toluidine blue (1 mg/ml) followed by laser irradiation using GaAlAs laser (630 nm, 10 mW/cm2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) using diode laser (630 nm, 10 mW)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Topical corticosteroid application (dexamethasone 0.5 mg in 5 ml water mouthwash for 5 min)
Number of subjects: 45
Study: 27437665

Group type: EXPERIMENTAL
Intervention: Severe low flow (SLF) group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Moderate low flow (MLF) group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Normal flow (NF) group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: MLF group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: NF group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: SLF group
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Independent predictors of 1-year mortality
Number of subjects: 984
Study: 24572083

Group type: EXPERIMENTAL
Intervention: Adapted CITI ethics certification training module
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard CITI ethics certification training module
Number of subjects: 40
Study: 22906262

Group type: EXPERIMENTAL
Intervention: 0.2 mg tamsulosin plus 0.5 mg dutasteride
Number of subjects: 216

Group type: COMPARATOR
Intervention: 0.2 mg tamsulosin
Number of subjects: 216